实用肝脏病杂志 ›› 2023, Vol. 26 ›› Issue (6): 781-784.doi: 10.3969/j.issn.1672-5069.2023.06.004

• 体外实验 • 上一篇    下一篇

miR-556-3p通过调控PTEN/AKT信号通路影响肝细胞癌的转移活性*

仲金龙, 施琳   

  1. 010059 呼和浩特市 内蒙古医科大学附属医院病理科
  • 收稿日期:2023-02-17 出版日期:2023-11-10 发布日期:2023-11-20
  • 通讯作者: 施琳,E-mail:cyxsg545@163.com
  • 作者简介:仲金龙,男,35岁,医学硕士,主治医师。研究方向:肿瘤病理与分子病理学研究
  • 基金资助:
    * 内蒙古自治区卫生健康委员会科技计划项目(编号:202201204)

MiR-556-3p affects the metastatic activity of HepG2 cells by regulating PTEN/AKT signaling pathway in vitro

Zhong Jinlong, Shi Lin   

  1. Department of Pathology, Affiliated Hospital, Inner Mongolia Medical University,Hohhot 010059, Inner Mongolia Autonomous Region, China
  • Received:2023-02-17 Online:2023-11-10 Published:2023-11-20

摘要: 目的 通过探索miR-556-3p在肝癌细胞发生发展过程中的作用机制,以期为肝细胞癌的预防和治疗提供一个新思路。方法 取肝细胞癌组织和癌旁肝组织,采用PCR法检测miR-556-3p水平,采用免疫组化法检测磷酸酯酶与张力蛋白同源物(PTEN)表达,采用荧光素酶法检测细胞作用靶点,应用miR-556-3p mimic、miR-556-3p NC、PTEN cDNA和PTEN siRNA转染HepG2细胞,采用Western blotting法检测PTEN/AKT信号通路相关蛋白表达。采用CCK-8法检测细胞增殖能力,采用Transwell法检测细胞侵袭力,使用流式细胞术检测细胞凋亡。应用生物信息学法预测miR-556-3p对HepG2细胞PTEN/AKT通路的调控作用。结果 肝癌组织miR-556-3p水平显著低于癌旁组织(P<0.05),HepG2细胞miR-556-3p水平显著低于正常肝细胞(P<0.05);荧光素酶分析显示,PTEN是miR-556-3p的直接靶点;miR-556-3p处理的HepG2细胞增殖、侵袭和凋亡率显著低于miR NC处理组(P<0.05);HepG2细胞PTEN过表达逆转了miR-556-3p对细胞生长抑制和凋亡诱导作用;miR-556-3p通过靶向PTEN抑制了HepG2细胞PTEN/AKT的激活。结论 肝癌组织miR-556-3p水平降低,而miR-556-3p可抑制肝癌细胞增殖、侵袭并诱导细胞凋亡。肝癌细胞PTEN受miR-556-3p调控,果提示miR-556-3p与肝癌的恶性发展密切相关。

关键词: 肝细胞癌, HepG2细胞, miR-556-3p, 磷酸酯酶与张力蛋白同源物/磷酸化蛋白激酶B, 增殖, 凋亡, 转移, 体外

Abstract: Objective This study aimed to explore the mechanism of miR-556-3p in the development of hepatocellular carcinogenesis. Methods The miR-556-3p level in cancerous and its adjacent non-cancerous tissues from patients with hepatocellular carcinoma was detected by real-time fluorescence quantitative PCR, and the phosphatase and tensin homolog (PTEN) expression was revealed by immunohistochemistry. The expression patterns of PTEN/ protein kinase B(Akt) signaling pathway-related proteins were detected by Western blotting after transfection of HepG2 cells with miR-556-3p mimic, miR-556-3p NC, PTEN cDNA and PTEN siRNA. The proliferation ability of HepG2 cells was studied by CCK-8 method, the invasion ability of cells was determined by Transwell method, and the apoptosis was detected by flow cytometry. The regulatory roles of miR-556-3p on PTEN/AKT pathway in HepG2 cells were evaluated by bioinformatics. Results The miR-556-3p loads in cancerous tissues was significantly lower than that in para-neoplastic tissues (P<0.05), and the miR-556-3p loads in HepG2 cells was also significantly lower than that in LO2 cells (P<0.05); the luciferase analysis showed that PTEN was a direct target of miR-556-3p; the proliferation rate, invasion rate and apoptosis rate in miR-556-3p-transfected HepG2 cells decreased significantly than in miR NC-transfected cells (P<0.05); the PTEN overexpression reversed the growth inhibition and apoptosis induction of miR-556-3p in HepG2 cells; the miR-556-3p inhibited PTEN/AKT activation by targeting PTEN. Conclusions The miR-556-3p loads decrease in hepatocellular carcinoma tissues, and the miR-556-3p inhibits the proliferation and invasion, and induce apoptosis in HepG2 cells. The PTEN is regulated by miR-556-3p in HepG2 cells. These findings above suggest that miR-556-3p is closely related to the transformation of liver cells, which needs further verification.

Key words: Hepatoma, HepG2 cells, miR-556-3p, Phosphatase and tensin homolog/ protein kinase B, Proliferation, Apoptosis, Metastasis, In vitro